FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2085189002> ?p ?o ?g. }

• W2085189002 endingPage "296" @default.
• W2085189002 startingPage "290" @default.
• W2085189002 abstract "Primary fibromyalgia syndrome (PFS) is a chronic disorder commonly seen in rheumatological practice. The pathophysiological disturbances of this syndrome, which was defined by the American College of Rheumatology in 1990, are poorly understood. This study evaluated, in 30 patients, the hypothesis that PFS is a pain modulation disorder induced by deregulation of serotonin metabolism.To compare platelet [(3)H]imipramine binding sites and serotonin (5-HT) levels in plasma-rich platelets (PRP) of PFS patients with those of matched healthy controls and to compare the levels of biogenic amine metabolites in the cerebrospinal fluid (CSF) of PFS patients with those of matched controls.Platelet [(3)H]imipramine binding sites were defined by two criteria, B(max) for their density and K(d) for their affinity. PRP 5-HT and CSF metabolites of 5-HT (5-hydroxyindoleacetic acid, 5-HIAA), norepinephrine (3-methoxy, 4-hydroxy phenylglycol, MHPG) and dopamine (homovanillic acid, HVA) were assayed by reversed-phase high-performance liquid chromatography with coulometric detection.[(3)H]Imipramine platelet binding was similar (P=0.43 for B(max) and P=0.30 for K(d)) in PFS patients (B(max)=901+/-83 fmol/mg protein, K(d)=0.682+/-0.046) and in matched controls (B(max)=1017+/-119 fmol/mg protein, K(d)=0.606+/-0.056). PRP 5-HT was significantly higher (P=0.0009) in PFS patients (955+/-101 ng/10(9) platelets) than in controls (633+/-50 ng/10(9) platelets). When adjusted for age, the levels of all CSF metabolites were lower in PFS patients. The CSF metabolite of norepinephrine (MHPG) was lower (P:=0.003) in PFS patients (8.33+/-0.33 ng/ml) than in matched controls (9.89+/-0.31 ng/ml) and 5-HIAA was lower (P=0.042) in PFS female patients (22.34+/-1.78 ng/ml) than in matched controls (25.75+/-1.75 ng/ml). For HVA in females, the difference between PFS patients (36.32+/-3.20 ng/ml) and matched controls (38.32+/-2.90 ng/ml) approached statistical significance (P=0.054).Changes in metabolites of CSF biogenic amines appear to be partially correlated to age but remained diagnosis-dependent. High levels of PRP 5-HT in PFS patients were associated with low CSF 5-HIAA levels in female patients but were not accompanied by any change in serotonergic uptake as assessed by platelet [(3)H]imipramine binding sites. These findings do not allow us to confirm that serotonin metabolism is deregulated in PFS patients." @default.
• W2085189002 created "2016-06-24" @default.
• W2085189002 creator A5002454183 @default.
• W2085189002 creator A5005920620 @default.
• W2085189002 creator A5038091716 @default.
• W2085189002 creator A5047928206 @default.
• W2085189002 creator A5057420314 @default.
• W2085189002 creator A5062063180 @default.
• W2085189002 creator A5087369824 @default.
• W2085189002 date "2001-03-01" @default.
• W2085189002 modified "2023-10-16" @default.
• W2085189002 title "Cerebrospinal fluid biogenic amine metabolites, plasma‐rich platelet serotonin and [3H]imipramine reuptake in the primary fibromyalgia syndrome" @default.
• W2085189002 cites W1688439786 @default.
• W2085189002 cites W1894736765 @default.
• W2085189002 cites W1981427133 @default.
• W2085189002 cites W1988031794 @default.
• W2085189002 cites W1988347806 @default.
• W2085189002 cites W1991735971 @default.
• W2085189002 cites W1992816698 @default.
• W2085189002 cites W1999794793 @default.
• W2085189002 cites W2004967981 @default.
• W2085189002 cites W2010928495 @default.
• W2085189002 cites W2018927155 @default.
• W2085189002 cites W2031221039 @default.
• W2085189002 cites W2031621995 @default.
• W2085189002 cites W2039465110 @default.
• W2085189002 cites W2040294385 @default.
• W2085189002 cites W2053342735 @default.
• W2085189002 cites W2067444992 @default.
• W2085189002 cites W2073846691 @default.
• W2085189002 cites W2081371398 @default.
• W2085189002 cites W2107387895 @default.
• W2085189002 cites W2107676335 @default.
• W2085189002 cites W2152596559 @default.
• W2085189002 cites W2253364553 @default.
• W2085189002 cites W2464584028 @default.
• W2085189002 cites W3171530618 @default.
• W2085189002 doi "https://doi.org/10.1093/rheumatology/40.3.290" @default.
• W2085189002 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11285376" @default.
• W2085189002 hasPublicationYear "2001" @default.
• W2085189002 type Work @default.
• W2085189002 sameAs 2085189002 @default.
• W2085189002 citedByCount "100" @default.
• W2085189002 countsByYear W20851890022012 @default.
• W2085189002 countsByYear W20851890022013 @default.
• W2085189002 countsByYear W20851890022014 @default.
• W2085189002 countsByYear W20851890022015 @default.
• W2085189002 countsByYear W20851890022016 @default.
• W2085189002 countsByYear W20851890022017 @default.
• W2085189002 countsByYear W20851890022018 @default.
• W2085189002 countsByYear W20851890022019 @default.
• W2085189002 countsByYear W20851890022021 @default.
• W2085189002 countsByYear W20851890022022 @default.
• W2085189002 crossrefType "journal-article" @default.
• W2085189002 hasAuthorship W2085189002A5002454183 @default.
• W2085189002 hasAuthorship W2085189002A5005920620 @default.
• W2085189002 hasAuthorship W2085189002A5038091716 @default.
• W2085189002 hasAuthorship W2085189002A5047928206 @default.
• W2085189002 hasAuthorship W2085189002A5057420314 @default.
• W2085189002 hasAuthorship W2085189002A5062063180 @default.
• W2085189002 hasAuthorship W2085189002A5087369824 @default.
• W2085189002 hasBestOaLocation W20851890021 @default.
• W2085189002 hasConcept C126322002 @default.
• W2085189002 hasConcept C134018914 @default.
• W2085189002 hasConcept C142724271 @default.
• W2085189002 hasConcept C170493617 @default.
• W2085189002 hasConcept C204787440 @default.
• W2085189002 hasConcept C2775841634 @default.
• W2085189002 hasConcept C2775864247 @default.
• W2085189002 hasConcept C2777831278 @default.
• W2085189002 hasConcept C2778377861 @default.
• W2085189002 hasConcept C2779145073 @default.
• W2085189002 hasConcept C2779651940 @default.
• W2085189002 hasConcept C71924100 @default.
• W2085189002 hasConcept C89560881 @default.
• W2085189002 hasConceptScore W2085189002C126322002 @default.
• W2085189002 hasConceptScore W2085189002C134018914 @default.
• W2085189002 hasConceptScore W2085189002C142724271 @default.
• W2085189002 hasConceptScore W2085189002C170493617 @default.
• W2085189002 hasConceptScore W2085189002C204787440 @default.
• W2085189002 hasConceptScore W2085189002C2775841634 @default.
• W2085189002 hasConceptScore W2085189002C2775864247 @default.
• W2085189002 hasConceptScore W2085189002C2777831278 @default.
• W2085189002 hasConceptScore W2085189002C2778377861 @default.
• W2085189002 hasConceptScore W2085189002C2779145073 @default.
• W2085189002 hasConceptScore W2085189002C2779651940 @default.
• W2085189002 hasConceptScore W2085189002C71924100 @default.
• W2085189002 hasConceptScore W2085189002C89560881 @default.
• W2085189002 hasIssue "3" @default.
• W2085189002 hasLocation W20851890021 @default.
• W2085189002 hasLocation W20851890022 @default.
• W2085189002 hasOpenAccess W2085189002 @default.
• W2085189002 hasPrimaryLocation W20851890021 @default.
• W2085189002 hasRelatedWork W1563937875 @default.
• W2085189002 hasRelatedWork W1971453675 @default.
• W2085189002 hasRelatedWork W2027622212 @default.
• W2085189002 hasRelatedWork W2027701078 @default.
• W2085189002 hasRelatedWork W2060612377 @default.

• next